Option Care Health (NASDAQ:OPCH) Posts Quarterly Earnings Results, Hits Estimates

Posted by Stanley Muller on Nov 5th, 2026

Option Care Health (NASDAQ:OPCH – Get Free Report) announced its quarterly earnings data on Wednesday. The company reported $0.49 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.49, FiscalAI reports. Option Care Health had a return on equity of 18.74% and a net margin of 3.68%. The business had revenue of $1.49 billion for the quarter, compared to analysts’ expectations of $1.48 billion. During the same period in the previous year, the business posted $0.45 EPS. The firm’s quarterly revenue was up 4.1% compared to the same quarter last year.

Option Care Health Price Performance

Shares of OPCH stock opened at $31.65 on Thursday. Option Care Health has a twelve month low of $18.01 and a twelve month high of $36.80. The stock has a market capitalization of $4.74 billion, a price-to-earnings ratio of 23.80, a P/E/G ratio of 1.93 and a beta of 0.47. The stock has a fifty day simple moving average of $26.99 and a two-hundred day simple moving average of $26.41. The company has a current ratio of 1.47, a quick ratio of 0.98 and a debt-to-equity ratio of 0.91.

Analyst Ratings Changes

Several analysts have recently weighed in on the stock. Weiss Ratings upgraded shares of Option Care Health from a “hold (c-)” rating to a “hold (c)” rating in a research report on Tuesday, October 20th. William Blair downgraded shares of Option Care Health from an “outperform” rating to a “market perform” rating in a research report on Tuesday, October 6th. Stephens cut Option Care Health from an “overweight” rating to an “equal weight” rating and lowered their price objective for the company from $30.00 to $24.00 in a research note on Friday, July 17th. Deutsche Bank Aktiengesellschaft cut Option Care Health from a “buy” rating to a “hold” rating and dropped their price objective for the company from $26.00 to $24.00 in a research report on Thursday, July 30th. Finally, Truist Financial set a $32.05 price objective on Option Care Health in a research report on Wednesday, October 7th. Two equities research analysts have rated the stock with a Buy rating and fourteen have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $29.48.

Read Our Latest Report on OPCH

Key Headlines Impacting Option Care Health

Here are the key news stories impacting Option Care Health this week:

Positive Sentiment: Q3 revenue rose 4.1% year over year to $1.49 billion, topping the $1.48 billion consensus estimate. Adjusted earnings were $0.49 per share, up from $0.45 a year earlier and ahead of Zacks’ $0.48 estimate (though in line with some other analyst estimates). The modest beat and continued growth could support investor sentiment. Zacks Q3 earnings article
Negative Sentiment: Option Care withdrew its financial guidance while its merger is pending. That limits near-term visibility into expected performance and may temper the positive impact of the quarterly results. Yahoo Finance Q3 results and guidance article
Neutral Sentiment: Law firms announced investigations into the fairness of the OPCH merger deal. These are preliminary inquiries, not findings of wrongdoing, but they add a potential source of deal-related uncertainty for shareholders. Merger investigation announcement

About Option Care Health

(Get Free Report)

Option Care Health, Inc is an independent provider of home and alternate-site infusion services in the United States. The company coordinates and delivers infusion therapy outside traditional hospital settings, including patients’ homes, ambulatory infusion suites and other outpatient locations.

Its services include administration of anti-infective therapies, immune globulin, nutrition support, inotropic therapies and medications used in the treatment of chronic and complex conditions.